[PHARMA] QoQ TTM Result on 31-Mar-2016 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
13-May-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
31-Mar-2016 [#1]
Profit Trend
QoQ- -15.96%
YoY- -28.96%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 2,189,022 2,286,356 2,295,554 2,276,603 2,189,312 2,136,265 2,113,938 2.34%
PBT 72,017 91,665 97,079 100,648 112,722 126,859 126,467 -31.18%
Tax -26,158 -28,865 -26,952 -29,520 -28,138 -21,695 -26,277 -0.30%
NP 45,859 62,800 70,127 71,128 84,584 105,164 100,190 -40.46%
-
NP to SH 45,599 62,497 69,407 70,629 84,044 104,679 99,663 -40.48%
-
Tax Rate 36.32% 31.49% 27.76% 29.33% 24.96% 17.10% 20.78% -
Total Cost 2,143,163 2,223,556 2,225,427 2,205,475 2,104,728 2,031,101 2,013,748 4.22%
-
Net Worth 531,169 531,250 524,177 515,906 529,786 534,373 528,477 0.33%
Dividend
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Div 41,442 51,803 64,750 69,935 77,704 90,625 88,011 -39.33%
Div Payout % 90.88% 82.89% 93.29% 99.02% 92.46% 86.57% 88.31% -
Equity
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Net Worth 531,169 531,250 524,177 515,906 529,786 534,373 528,477 0.33%
NOSH 259,377 259,146 258,981 258,859 259,064 259,027 259,057 0.08%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin 2.09% 2.75% 3.05% 3.12% 3.86% 4.92% 4.74% -
ROE 8.58% 11.76% 13.24% 13.69% 15.86% 19.59% 18.86% -
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
RPS 844.83 882.26 886.38 879.48 845.08 824.73 816.01 2.33%
EPS 17.60 24.12 26.80 27.28 32.44 40.41 38.47 -40.48%
DPS 16.00 20.00 25.00 27.00 30.00 35.00 34.00 -39.36%
NAPS 2.05 2.05 2.024 1.993 2.045 2.063 2.04 0.32%
Adjusted Per Share Value based on latest NOSH - 258,859
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
RPS 151.88 158.64 159.27 157.96 151.90 148.22 146.67 2.34%
EPS 3.16 4.34 4.82 4.90 5.83 7.26 6.92 -40.55%
DPS 2.88 3.59 4.49 4.85 5.39 6.29 6.11 -39.29%
NAPS 0.3685 0.3686 0.3637 0.358 0.3676 0.3708 0.3667 0.32%
Price Multiplier on Financial Quarter End Date
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Date 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 -
Price 5.30 5.58 5.50 5.76 6.36 6.50 7.13 -
P/RPS 0.63 0.63 0.62 0.65 0.75 0.79 0.87 -19.28%
P/EPS 30.12 23.14 20.52 21.11 19.60 16.08 18.53 38.04%
EY 3.32 4.32 4.87 4.74 5.10 6.22 5.40 -27.58%
DY 3.02 3.58 4.55 4.69 4.72 5.38 4.77 -26.16%
P/NAPS 2.59 2.72 2.72 2.89 3.11 3.15 3.50 -18.11%
Price Multiplier on Announcement Date
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Date 21/02/17 21/11/16 19/08/16 13/05/16 15/02/16 26/11/15 17/08/15 -
Price 5.05 5.70 5.62 5.60 6.19 6.50 5.65 -
P/RPS 0.60 0.65 0.63 0.64 0.73 0.79 0.69 -8.85%
P/EPS 28.70 23.64 20.97 20.52 19.08 16.08 14.69 55.96%
EY 3.48 4.23 4.77 4.87 5.24 6.22 6.81 -35.95%
DY 3.17 3.51 4.45 4.82 4.85 5.38 6.02 -34.66%
P/NAPS 2.46 2.78 2.78 2.81 3.03 3.15 2.77 -7.57%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment